Investor profile
Bruno Holthof
Family Office, Private equity, Venture capital & Chair of the Supervisory Board Health and Care Fund at Gimv, Visiting Professor at University of Oxford North American Office, Partner at Eqt Life Sciences
Bruno Holthof works as a Partner at Eqt Life Sciences. The firm's known portfolio counts 10 companies.
Is Bruno Holthof a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
Contacts
Affiliated funds' portfolios
Chair of the Supervisory Board Health and Care Fund at Gimv, whose known portfolio counts 10 companies
- ONWARD
- Exciva
- Kinaset Therapeutics
- ImmunOs Therapeutics
- FIRE1
- Kivu Bioscience
- Onera Health
- Spineart
- Citymesh
- Curana
Visiting Professor at University of Oxford North American Office, whose known portfolio counts 10 companies
- OXCCU
- OrganOx
- Beacon Therapeutics
- Ultromics
- FluoRok
- Oxford Endovascular
- Wild Bioscience
- Diffblue
- Seloxium
- Bizumi
Partner at Eqt Life Sciences, whose known portfolio counts 10 companies
- ONWARD
- Tubulis
- Artios Pharma
- Tenpoint Therapeutics
- Electra Therapeutics
- Exciva
- Kinaset Therapeutics
- FoRx Therapeutics
- Neurent Medical
- Xeltis
Investor Profile
The listing covers sectors AI, Climate, Food and Hardware, and focus areas AgriTech, Benelux, Biotech and Clean Energy. Startups operating in these areas may find Bruno Holthof relevant.
Stage-wise, the deals at Eqt Life Sciences cluster around Growth, Late-Stage and Seed rounds.
The firm portfolio and the focus above give founders context on whether Bruno Holthof matches their raise.
Colleagues
Showing 20 of 46
Chris Morton
Royal Society Entrepreneur in Residence
London, United Kingdom
Houman Ashrafian
Head of Experimental Therapeutics
London, United Kingdom
Christoph Kocher
Senior Principal Life Sciences Venture Capital
Munich, Germany
Niklas Windmann
Principal
Munich, Germany
Thomas Goudriaan
Private Equity - Principal
The Hague, Netherlands
Gautier Lefebvre
Healthcare investor - Partner
Paris, France
Guillaume Bardy
Partner
Paris, France
Maja Markovic
Partner
Munich, Germany
Merijn Klaassen
CFO & COO EQT Life Sciences (formerly LSP)
Tilburg, Netherlands
Cillian King
Investor
Amsterdam, Netherlands
Fouad Azzam
Partner
Boston, United States
John de Koning
Partner
Amsterdam, Netherlands
Anne Portwich
Partner
Amsterdam, Netherlands
Daniela Begolo
Managing Director
Amsterdam, Netherlands
Maximilian Moser
Vice President
London, United Kingdom
Philipp Bräuer
Vice President
Munich, Germany
Juliette Lee
VP
Amsterdam, Netherlands
Francesco Cesarini
Lecturer
Italy
Nicolas de Saint Laon
Partner
Paris, France
François-Xavier Rico
Principal
Paris, France
Frequently asked questions
Who is Bruno Holthof?
Bruno Holthof is a family office investor and private equity investor based in Oxford, England, United Kingdom, listed as Partner at Eqt Life Sciences. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Bruno Holthof personally.
What does Bruno Holthof invest in?
Listed sectors include AI, Climate, Food and Hardware; listed focus areas include AgriTech, Benelux, Biotech and Clean Energy. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Bruno Holthof invest at?
Eqt Life Sciences appears in Growth, Late-Stage and Seed rounds across its known deals, and Bruno Holthof is listed there as Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Bruno Holthof listed at?
Bruno Holthof is listed as Partner at Eqt Life Sciences. 46 other people in the database share a firm with Bruno Holthof.
How do I contact Bruno Holthof?
An email address and a LinkedIn page are on file for Bruno Holthof. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal